CytomX Therapeutics (CTMX) Receivables - Other (2016 - 2025)
Historic Receivables - Other for CytomX Therapeutics (CTMX) over the last 11 years, with Q3 2025 value amounting to $1.1 million.
- CytomX Therapeutics' Receivables - Other changed 0.0% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.1 million for FY2024, which is 5000.0% down from last year.
- According to the latest figures from Q3 2025, CytomX Therapeutics' Receivables - Other is $1.1 million, which was down 0.0% from $1.2 million recorded in Q2 2025.
- In the past 5 years, CytomX Therapeutics' Receivables - Other registered a high of $35.0 million during Q4 2022, and its lowest value of $800000.0 during Q1 2021.
- For the 5-year period, CytomX Therapeutics' Receivables - Other averaged around $3.5 million, with its median value being $1.1 million (2024).
- As far as peak fluctuations go, CytomX Therapeutics' Receivables - Other tumbled by 9900.0% in 2021, and later soared by 427500.0% in 2022.
- Quarter analysis of 5 years shows CytomX Therapeutics' Receivables - Other stood at $800000.0 in 2021, then skyrocketed by 4275.0% to $35.0 million in 2022, then tumbled by 93.71% to $2.2 million in 2023, then crashed by 50.0% to $1.1 million in 2024, then changed by 0.0% to $1.1 million in 2025.
- Its Receivables - Other stands at $1.1 million for Q3 2025, versus $1.2 million for Q2 2025 and $1.0 million for Q1 2025.